Rapport Therapeutics Inc (RAPP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Operating Expenses | 29,986 | 29,496 | 27,108 | 23,521 | 21,640 |
| Operating Income | -29,986 | -29,496 | -27,108 | -23,521 | -21,640 |
| Other Income | 3,061 | 2,764 | 3,045 | 3,541 | 4,103 |
| Pre-tax Income | -26,925 | -26,732 | -24,063 | -19,980 | -17,537 |
| Net Income Continuous | -26,925 | -26,732 | -24,063 | -19,980 | -17,537 |
| Net Income | $-26,925 | $-26,732 | $-24,063 | $-19,980 | $-17,537 |
| EPS Basic Total Ops | -0.71 | -0.75 | -0.68 | 9.49 | -0.50 |
| EPS Basic Continuous Ops | -0.71 | -0.75 | -0.68 | 9.50 | -0.50 |
| EPS Diluted Total Ops | -0.71 | -0.75 | -0.68 | 9.49 | -0.50 |
| EPS Diluted Continuous Ops | -0.71 | -0.75 | -0.68 | 9.50 | -0.50 |
| EPS Diluted Before Non-Recurring Items | -0.71 | -0.75 | -0.68 | -0.57 | -0.50 |
| EBITDA(a) | $-29,526 | $-29,336 | $-27,300 | $-22,701 | $-23,385 |